Does your small business need early-stage financing to take its cancer research to the next level?
The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center has released $10 million for new contract funding opportunities to support cancer research and technology development in key emerging areas of need. The NCI SBIR can help you finance and advance innovations in cancer prevention, diagnosis, treatment, and basic research. Applications are due by 5 p.m. ET on Tuesday, November 13, 2012. The NCI solicits proposals for SBIR contracts only once annually, so don't miss your chance!
The FY2013 NIH/CDC SBIR contract solicitation provides funding opportunities to small businesses to support the research, development, and ultimately commercialization in the following areas including:
Advancing Cancer Research
- 314 Development of Human Tissue Culture Systems that Mimic the Tumor Microenvironment
- 319 Technology to Generate Anti–Peptide Capture Reagents for Affinity-Enriched Proteomic Studies
- 320 High Quality Cancer–Related Standards for Metabolomics Research
- 321 Chemically Defined Glycan Libraries for Reference Standards and Glycomics Research (Joint NCI-NIGMS Program)
If you have questions about any of the topics or general questions on contract administration, please contact:
Ms. Bette Shanahan
E-mail: eshanahan@mail.nih.gov
Phone: (301) 435-3782